Healthcare/Medical Simulation Market – By Product (Patient Simulator, Surgical Simulator, Imaging Simulation, Task Trainer), Technology (Haptic, Virtual Reality), End-Users (Academics, Hospitals, Military) & Services– Trends & Global Forecasts To 2017

Publisher Name :
Date:14-Jun-2013
No. of pages: 307
Inquire Before Buying

Fueled by the growing focus on patient safety and technological advancements, the healthcare/medical simulation industry has experienced significant growth over the past decade, except for the past 3 to 4 years, where the market witnessed slow growth due to the global recession. A pivotal factor in the growth of this market has been high fidelity mannequins/patient simulators, which have witnessed substantial growth in recent years owing primarily to recent technological advancements that have created highly realistic simulators competent of very high levels of fidelity. Increasing healthcare costs, rising demand for minimally invasive treatment, and increasing consolidation of manufacturers further propels the market. However, the high cost of simulators, economic slowdown in the developed region, and limited availability of funds inhibits the growth of the market, to a certain extent.

The global healthcare/medical simulation market is broadly segmented into products and services. The market was valued at $790.1 million in 2012 and is poised to grow at a CAGR of 19.6% in the forecast period to reach $1930.5 million by 2017.

North America is the largest market for healthcare/medical simulation, with the U.S. contributing a major share, followed by Europe, and Asia. The Asian market, especially India and China, is expected to witness a boost in demand for medical simulation products and services and is poised to register maximum growth over the next five years, as a result of its economic development.

Prominent players in this market are Laerdal Medical (Norway), CAE Healthcare (Canada), Simulaids (U.S.), Gaumard (U.S.), Kyoto Kagako (Japan), Limbs and Things (U.K.), Education Management Solutions (U.S.), and Mentice AB (Sweden).

Scope of the Report:

This research report largely categorizes the global market for healthcare/medical simulation into products and services. This market is broken down into segments and sub-segments, providing exhaustive value analysis for 2010, 2011 and 2012, as well as forecast up to 2017. The market is also evaluated by end-users and comprehensively analyzed at a granular level by region (North America, Europe, Asia, and Rest of the World (RoW).

Global Healthcare/medical simulation Products & Services Market

  • High Fidelity Mannequin/ Patient Simulators
  • Simulated Clinical Environments
  • Live environments
  • Virtual environments
  • Second life
  • Serious games
  • Interventional simulation
  • Surgical simulators
  • Cardiovascular simulators
  • IV simulators
  • Endovascular simulators
  • Ultrasound simulators
  • Mid / Low Fidelity Task Trainers
  • Imaging Simulation
  • Ultrasound Imaging
  • Magnetic Resonance Imaging (MRI)
  • Computed Tomography (CT)
  • Positron Emission Tomography (PET)
  • Performance Recording
  • Healthcare/medical simulation training services

Technology Landscape

  • Haptics
  • Virtual reality

Global Healthcare / Medical Simulation Market, By End-Users

  • Academics
  • Hospitals
  • Military
  • Other

GlobalHealthcare / Medical Simulation Market, By Geography

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Spain
  • Italy
  • RoE
  • Asia
  • Japan
  • India
  • China
  • RoA
  • Rest of the World (RoW)
  • LATAM
  • Pacific
  • Middle East & Africa

Healthcare/Medical Simulation Market – By Product (Patient Simulator, Surgical Simulator, Imaging Simulation, Task Trainer), Technology (Haptic, Virtual Reality), End-Users (Academics, Hospitals, Military) & Services– Trends & Global Forecasts To 2017

Table Of Contents

1 Introduction 18
1.1 Key Take-Aways 18
1.2 Report Description 18
1.3 Markets Covered 19
1.4 Stakeholders 21
1.5 Research Methodology 22
1.5.1 Market Size 22
1.5.2 Market Share 22
1.5.3 Key Data Points From Secondary Sources 23
1.5.4 Key Data Points From Primary Sources 23
1.5.5 Details Of Primary Interviewees 24
1.5.6 Assumptions 25

2 Executive Summary 26

3 Market Overview 29
3.1 Introduction 30
3.2 Market Segmentation 31
3.3 Market Dynamics 33
3.3.1 Drivers 34
3.3.1.1 Increasing Healthcare Costs Create a Need for Medical Simulation Technologies 34
3.3.1.2 Continuous Innovation in Technologies to Drive the Market 34
3.3.1.3 Increasing Demand for Minimally Invasive Treatments is Projected to Fuel the Need for Medical Simulation 35
3.3.1.4 Increasing Focus on Patient Safety to Drive the Market 36
3.3.1.5 Increasing Consolidation of Manufacturers to Propel the Market 36
3.3.2 Restraints 37
3.3.2.1 Limited Availability of Funds Inhibit Growth 37
3.3.2.2 Economic Slowdown to Inhibit Growth 37
3.3.2.3 High cost of Simulators to Restrict Growth of the Market 38
3.3.3 Opportunities 38
3.3.3.1 Untapped Emerging Markets Offer Growth Opportunities 38
3.3.3.2 Shortages of Service Providers Present Significant Prospects for Growth 39
3.4 Market Share Analysis 40
3.4.1 High Fidelity Mannequins/Patient Simulators, By Key Player 40
3.4.2 Mid/Low Fidelity Task Trainers,By Key Player 41
3.4.3 Performance Recording, By Key Player 42

4 Global Medical Simulation Products & Services Market 44
4.1 Introduction 45
4.2 High Fidelity Mannequins/Patient Simulators 48
4.3 Simulated Clinical Environments 50
4.3.1 Live Environments 51
4.3.2 Virtual Environments 52
4.3.2.1 Second Life 54
4.3.2.2 Serious Games 56
4.4 Interventional Simulators 58
4.4.1 Surgical Simulators 60
4.4.2 Cardiovascular Simulators 61
4.4.3 Iv Simulators 62
4.4.4 Endovascular Simulators 63
4.4.5 Ultrasound Simulators 65
4.5 Low Fidelity Task Trainers 67
4.6 Imaging Simulation 69
4.6.1 Ultrasound Imaging Simulation 71
4.6.2 Magnetic Resonance Imaging (Mri) Simulation 72
4.6.3 Computed Tomography (Ct) Simulation 74
4.6.4 Positron Emission Tomography (Pet) Simulation 75
4.7 Performance Recording 76
4.8 Simulation Training Services 78

5 Technology Landscape 80
5.1 Haptics 80
5.2 Virtual Reality 81

6 Applications Market 83
6.1 Introduction 83
6.2 Academics 84
6.3 Hospitals 85
6.4 Military 85
6.5 Other 86

7 Geographic Analysis 87
7.1 Introduction 88
7.2 North America 89
7.3 Europe 104
7.4 Asia 121
7.5 Row 138

8 Competitive Landscape 154
8.1 Introduction 154
8.2 Mergers & Acquisitions 159
8.3 Agreements, Partnerships, Collaborations & Joint Ventures 162
8.4 New Product Launch 170
8.5 Expansion 179
8.6 Other Developments 181

9 Company Profiles 183
(Overview, Financials, Products & Services, Strategy, & Developments)*
9.1 3b Scientific Gmbh 183
9.2 Anesoft Corporation 197
9.3 Anomalous Medical 200
9.4 Biodigital Systems, Llc 202
9.5 B-Line Medical, Llc (Subsidiary Ofatellis, Inc. ) 204
9.6 Cae, Ltd. 208
9.7 Education Management Solutions, Inc. (Ems) 219
9.8 Gaumard Scientific Company, Inc. 223
9.9 Immersion Corporation 234
9.10 Ingmar Medical, Ltd. 239
9.11 Kyoto Kagaku Co., Ltd. 242
9.12 Laerdal Medical As 246
9.13 Limbs & Things Ltd 258
9.14 Medical Simulation Corporation 270
9.15 Mentice Ab 275
9.16 Promodel Corporation 278
9.17 SIMBIONIX USA CORPORATION 282
9.18 SIMULAB CORPORATION 289
9.19 SIMULAIDS, INC. 302
9.20 SURGICAL SCIENCE SWEDEN AB 313
*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.

List Of Tables

Table 1 Healthcare/Medical Simulation Products & Services Market, By Geography, 2010 – 2017 ($Million) 27
Table 2 Global Healthcare/Medical Simulation Products & Services Market, By Type, 2010 – 2017 ($Million) 46
Table 3 Healthcare/Medical Simulation Products & Services Market, By Geography, 2010 – 2017 ($Million) 47
Table 4 High Fidelity Mannequins/Patient Simulators Market, By Geography, 2010 – 2017 ($Million) 49
Table 5 Global Simulated Clinical Environments Market, 2010 – 2017 ($Million) 50
Table 6 Simulated Clinical Environments Market, 2010 – 2017 ($Million) 51
Table 7 Live Environments Market, 2010 – 2017 ($Million) 52
Table 8 Global Virtual Environment Market, 2010 – 2017 ($Million) 53
Table 9 Virtual Environments Market, 2010 – 2017 ($Million) 54
Table 10 Second Life Market, By Geography, 2010 – 2017 ($Million) 55
Table 11 Serious Games Market, By Geography, 2010 – 2017 ($Million) 57
Table 12 Global Interventional Simulators Market, 2010 – 2017 ($Million) 58
Table 13 Interventional Simulators Market, 2010 – 2017 ($Million) 59
Table 14 Surgical Simulators Market, 2010 – 2017 ($Million) 60
Table 15 Cardiovascular Simulators Market, 2010 – 2017 ($Million) 62
Table 16 Iv Simulators Market, By Geography, 2010 – 2017 ($Million) 63
Table 17 Endovascular Simulators Market, 2010 – 2017 ($Million) 64
Table 18 Ultrasound Simulators Market, 2010 – 2017 ($Million) 66
Table 19 Low Fidelity Task Trainers Market, 2010 – 2017 ($Million) 68
Table 20 Global Imaging Simulation Market, 2010 – 2017 ($Million) 70
Table 21 Imaging Simulation Market, 2010 – 2017 ($Million) 71
Table 22 Ultrasound Imaging Simulation Market, 2010 – 2017 ($Million) 72
Table 23 Magnetic Resonance Imaging (Mri) Simulation Market, By Geography, 2010 – 2017 ($Thousand) 73
Table 24 Computed Tomography (Ct) Simulation Market, By Geography, 2010 – 2017 ($Thousand) 74
Table 25 Positron Emission Tomography (Pet) Simulation Market, By Geography, 2010 – 2017 ($Thousand) 75
Table 26 Performance Recording Market, 2010 – 2017 ($Million) 77
Table 27 Simulation Training Services Market, 2010 – 2017 ($Million) 79
Table 28 Healthcare/Medical Simulation Market, 2010 – 2017 ($Million) 88
Table 29 North America: Healthcare/Medical Simulation Products & Services Market, By Type, 2010 – 2017 ($Million) 91
Table 30 North America: Healthcare/Medical Simulation Products & Services Market, By Country, 2010 – 2017 ($Million) 92
Table 31 North America: High Fidelity Mannequin/Patient Simulators Market, By Country, 2010 – 2017 ($Million) 93
Table 32 North America: Simulated Clinical Environments Market, By Type, 2010 – 2017 ($Million) 94
Table 33 North America: Simulated Clinical Environments Market, By Country, 2010 – 2017 ($Million) 95
Table 34 North America: Live Environments Market, By Country, 2010 – 2017 ($Million) 96
Table 35 North America: Virtual Environment Market, 2010 – 2017 ($Million) 96
Table 36 North America: Second Life Market, By Country, 2010 – 2017 ($Million) 97
Table 37 North America: Serious Games Market, By Country, 2010 – 2017 ($Million) 98
Table 38 North America: Interventional Simulators Market By Type, 2010 – 2017 ($Million) 99
Table 39 North America: Interventional Simulators Market, By Country, 2010 – 2017 ($Million) 100
Table 40 North America: Imaging Simulation Market, 2010 – 2017 ($Thousand) 101
Table 41 North America: Imaging Simulation Market, By Country, 2010 – 2017 ($Million) 102
Table 42 North America: Performance Recording Market, By Country, 2010 – 2017 ($Million) 102
Table 43 North America: Simulation Training Services Market, By Country, 2010 – 2017 ($Million) 103
Table 44 Europe: Healthcare/Medical Simulation Products & Services Market, By Type, 2010 – 2017 ($Million) 105
Table 45 Europe: Healthcare/Medical Simulation Products & Services Market, By Country, 2010 – 2017 ($Million) 106
Table 46 Europe: High Fidelity Mannequin/Patient Simulator Market, By Country, 2010 – 2017 9$Million) 107
Table 47 Europe: Simulated Clinical Environments Market, By Type, 2010 – 2017 ($Million) 108
Table 48 Europe: Simulated Clinical Environments Market, By Country, 2010 – 2017 ($Million) 109
Table 49 Europe: Live Environments Market, By Country Market, By Country, 2010 – 2017 ($Million) 110
Table 50 Europe: Virtual Environment Market, 2010 – 2017 ($Million) 111
Table 51 Europe: Virtual Environments Market, By Country, 2010 – 2017 ($Million) 112
Table 52 Europe: Second Life Market, By Country, 2010 – 2017 ($Thousand) 113
Table 53 Europe: Serious Games Market, By Country, 2010 – 2017 ($Million) 114
Table 54 Europe: Interventional Simulators Market, 2010 – 2017 ($Million) 115
Table 55 Europe: Interventional Simulators Market, By Country, 2010 – 2017 ($Million) 116
Table 56 Europe: Imaging Simulation Market, 2010 – 2017 ($Thousand) 117
Table 57 Europe: Imaging Simulation Market, By Country, 2010 – 2017 ($Million) 118
Table 58 Europe: Performance Recording Market, By Country, 2010 – 2017 ($Million) 119
Table 59 Europe: Simulation Training Services Market, By Country, 2010 – 2017 ($Million) 120
Table 60 Asia: Healthcare/Medical Simulation Products & Services Market, By Type, 2010 – 2017 ($Million) 122
Table 61 Asia: Healthcare/Medical Simulation Products & Services Market, By Country, 2010 – 2017 ($Million) 123
Table 62 Asia: High Fidelity Mannequin/ Patient Simulator Market, By Country, 2010 – 2017 ($Million) 124
Table 63 Asia: Simulated Clinical Environments Market, 2010 – 2017 ($Million) 125
Table 64 Asia: Simulated Clinical Environments Market, By Country, 2010 – 2017 ($Million) 126
Table 65 Asia: Live Environments Market, By Country, 2010 – 2017 ($Million) 127
Table 66 Asia: Virtual Environment Market, 2010 – 2017 ($Million) 128
Table 67 Asia: Virtual Environments Market, By Country, 2010 – 2017 ($Million) 129
Table 68 Asia: Second Life Market, By Country, 2010 – 2017 ($Thousand) 130
Table 69 Asia: Serious Games Market, By Country, 2010 – 2017 ($Million) 131
Table 70 Asia: Interventional Simulators Market 2010 – 2017 ($Million) 132
Table 71 Asia: Interventional Simulators Market, By Country, 2010 – 2017 ($Million) 133
Table 72 Asia: Imaging Simulation Market, 2010 – 2017 ($Thousand) 134
Table 73 Asia: Imaging Simulation Market, By Country, 2010 – 2017 ($Thousand) 135
Table 74 Asia: Performance Recording Market, By Country, 2010 – 2017 ($Thousand) 136
Table 75 Asia: Simulation Training Services Market, By Country, 2010 – 2017 ($Million) 137
Table 76 Row: Healthcare/Medical Simulation Products & Services Market, By Type, 2010 – 2017 ($Million) 139
Table 77 Row:Healthcare/Medical Simulation Products & Services Market, By Country, 2010 – 2017 ($Million) 140
Table 78 Row: High Fidelity Mannequin/Patient Simulator Market, By Country, 2010 – 2017 ($Million) 141
Table 79 Row: Simulated Clinical Environments Market, 2010 – 2017 ($Million) 141
Table 80 Row: Simulated Clinical Environments Market, By Country, 2010 – 2017 ($Million) 142
Table 81 Row: Live Environments Market, By Country Market, By Country, 2010 – 2017 ($Million) 143
Table 82 Row: Virtual Environment Market, 2010 – 2017 ($Million) 144
Table 83 Row: Virtual Environments Market, By Country, 2010 – 2017 ($Million) 145
Table 84 Row: Second Life Market, By Country, 2010 – 2017 ($Thousand) 146
Table 85 Row: Serious Games Market, By Country, 2010 – 2017 ($Thousand) 147
Table 86 Row: Interventional Simulators Market 2010 – 2017 ($Thousand) 148
Table 87 Row: Interventional Simulators Market, By Country, 2010 – 2017 ($Thousand) 149
Table 88 Row: Imaging Simulation Market, 2010 – 2017 ($Thousand) 150
Table 89 Row: Imaging Simulation Market, By Country, 2010 – 2017 ($Thousand) 151
Table 90 Row: Performance Recording Market, By Country, 2010 – 2017 ($Thousand) 152
Table 91 Row: Simulation Training Services Market, By Country, 2010 – 2017 ($Thousand) 153
Table 92 Mergers & Acquisitions, 2010 – 2012 159
Table 93 Agreements, Partnerships, Collaborations, Contracts & Joint Ventures, 2010 – 2013 162
Table 94 New Product Launch, 2010 – 2013 170
Table 95 Expansion, 2010 – 2012 179
Table 96 Other Developments, 2010 – 2013 181
Table 97 Cae, Ltd.: Total Revenue And R&D Expenditure, 2010 – 2012 ($Million) 209
Table 98 Cae, Ltd.: Total Revenue, By Segment, 2010 – 2012 ($Million) 209
Table 99 Cae, Ltd.: Total Revenue, By Geography, 2010 – 2012 ($Million) 211
Table 100 Immersion Corporation: Total Revenue And R&D Expenditure, 2010 – 2012 ($Million) 235
Table 101 Immersion Corporation: Total Revenue, By Segment, 2010 – 2012 ($Million) 235
Table 102 Immersion Corporation: Total Revenue, 2010 – 2012 ($Million) 236

List Of Figures

Figure 1 Healthcare/Medical Simulation Market, Segmental Analysis, 2012 26
Figure 2 Market Segmentation Of Healthcare/ Medical Simulation Market 31
Figure 3 Market Dynamics 33
Figure 4 Market Share Analysis: Global High Fidelity Mannequins/Patient Simulators, By Key Player, 2012 40
Figure 5 Global Mid/Low Fidelity Task Trainers Market Share Analysis, By Key Players, 2012 41
Figure 6 Global Performance Recording Market Share Analysis, By Key Players, 2012 42
Figure 7 Global Healthcare/Medical Simulation Market Revenue, By End-User, 2010 - 2017 ($Million) 83
Figure 8 Key Growth Strategies, 2010 – 2013 154
Figure 9 Key Players Focusing On New Product Launch, 2010 – 2013 156
Figure 10 Key Players Focusing On Agreements, Partnerships, Collaborations, Contracts And Joint Ventures, 2010 – 2013 157
Figure 11 Key Players Focusing On Mergers & Acquisitions, 2010 – 2013 158

  • No items
  • Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
  • Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

  • Asia-Pacific, Led by China, Drive the Global Methanol Industry
  • China is driving the global methanol industry, with tremendous demand from both its energy and petrochemicals sectors. It accounts for 87.9% of Asia-Pacific’s (APAC) methanol capacity, and 51.9% of the global methanol capacity. Despite a large planned capacity increase in …

  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • Chronic Lymphocytic Leukemia (CLL) Treatment Market worth $3.3 billion by 2018
  • New Entrants to Boost Chronic Lymphocytic Leukemia Treatment Market Value to $3.3 Billion by 2018, says GlobalData. The introduction of several new drugs will accelerate growth in the Chronic Lymphocytic Leukemia (CLL) treatment market, from $1.4 billion in 2013 to …

  • Zambia Pharmaceuticals and Healthcare Report Q4 2014
    Published: 20-Aug-2014        Price: US $1295 Onwards        Pages: 61
    BMI View: The disparity between urban and rural healthcare provision in Zambia is showing signs of being addressed, with the recent opening of the first ever hospital to serve the district of Chienge. This, along with ongoing governmental training initiatives aimed at improving the skills of Zambian healthcare professionals, is likely to attract talent to the country. That said, speculation over President Sata's ill health, along with delays in the construction of 650 healthcare clinics across t......
  • Australia Pharmaceuticals and Healthcare Report Q4 2014
    Published: 20-Aug-2014        Price: US $1295 Onwards        Pages: 135
    BMI View: Over 300 drug formulations listed on the Pharmaceutical Benefits Scheme (PBS) will be subject to price reduction from October 1 2014, following the first simplified price disclosure (SPD) cycle in Australia. As a result, the prices of the affected drugs will be lowered by 20% on average, from those in April 2014. The Australian government continues to push price controls on pharmaceuticals. This is a reflection of the fact that high prices are no longer accepted by patients and nationa......
  • Croatia Pharmaceuticals and Healthcare Report Q4 2014
    Published: 20-Aug-2014        Price: US $1295 Onwards        Pages: 102
    BMI View: Heavy price cuts and margin restrictions within the pharmaceutical supply chain threaten to cause drug shortages and weaken the supply chain within Croatia, with product withdrawals expected and the HZZO braced for revolt from pharmacies and wholesalers. We forecast weak pharmaceutical market growth over the next decade, in light of Croatia's acceding to EU pressure to rein in its budget deficit. Liquidity issues and payment terms will remain unfavourable in 2014, but with Croatia's ec......
  • Kenya Pharmaceuticals and Healthcare Report Q4 2014
    Published: 20-Aug-2014        Price: US $1295 Onwards        Pages: 106
    BMI View: Investment into Kenya's healthcare sector by pharmaceutical and medical device companies is an advisable business strategy - as highlighted by the high growth forecast in healthcare spending between 2013 and 2018. However, we note that there are downside risks to our forecast, including government inefficiencies and the out-of-pocket characteristics of the market, which will act as challenges for companies looking for a rapid return on investment. Headline Expenditure Projections ? Pha......
  • Latvia Pharmaceuticals and Healthcare Report Q4 2014
    Published: 20-Aug-2014        Price: US $1295 Onwards        Pages: 107
    BMI View: Latvia's macroeconomic environment continues to improve at the same time as smooth transitions to a new currency and new Prime Minister. Market growth forecasts are strong although the country will continue to present a modest opportunity to larger multinational companies on account of its relatively small market size. Meanwhile, tensions between Ukraine and Russia may provide challenges for local manufacturers looking towards exports to Russia to boost revenue. Headline Expenditure Pr......
  • Mexico Pharmaceuticals and Healthcare Report Q4 2014
    Published: 20-Aug-2014        Price: US $1295 Onwards        Pages: 144
    BMI View: The lack of a unified reimbursement system, the absence of widespread private health insurance, relatively low healthcare spending and the promotion of generic drugs in Mexico will continue to undermine revenue-generating opportunities for innovative drugmakers. However, over the long term, healthier fiscal revenue due to energy reform will encourage the Mexican government to further increase public spending on medical services and improve national healthcare standards.. Headline Expen......
  • Thailand Pharmaceuticals and Healthcare Report Q4 2014
    Published: 20-Aug-2014        Price: US $1295 Onwards        Pages: 115
    BMI View: Thailand offers several revenue earning opportunities to drugmakers due to its ageing population and the presence of a universal healthcare system that provides the population with access to healthcare. However cost containment policies and delays in patent approvals limit the attractiveness of the country to multinational pharmaceutical firms. Headline Expenditure Projections ? Pharmaceuticals: THB142.5bn (USD4.64bn) in 2013 to THB146.5bn (USD4.5bn) in 2014; +2.8% in local currency te......
  • China Hospital Development and Investment Report, 2014-2017
    Published: 18-Aug-2014        Price: US $2500 Onwards        Pages: 157
    China hospital industry has been developing quickly in recent years, thanks to the market demand stimulus and steady progress in health care reform. The number of Chinese hospitals grew at a CAGR of 6% in 2011-2013, higher than 2.26% in 2005-2010. The revenue of China hospital industry jumped at a CAGR of 23.6% in 2011-2013, and it is expected to maintain the growth rate of over 20% and hit RMB4.07 trillion in 2017.At the same time, various social capital flows to the Chinese hospital market......
  • SeeNews Research on Demand Human health activities, Georgia – Company Names, Contacts, Key Managers and Financial Figures
    Published: 18-Aug-2014        Price: US $1100 Onwards        
    SeeNews Research on Demand Human health activities, Georgia report provides you the most up-to-date and easy-to-use information of 1,587 companies, operating on the Human health activities, Georgia. The information you can find about the companies:Company Name Identification Number Headquarters Address Postcode Phone Number Fax Number Legal Form Date of Establishment Website E-mail Operational/Non-operational NACE 2.0 Industry Code NACE 2.0 Industry Description K......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs